Regulatory post‐market drug safety advisories on cardiac harm: A comparison of four national regulatory agencies
Abstract Information on rare adverse effects is often limited when a medication is initially approved for marketing. Medicines regulators use safety advisories to warn health professionals and consumers about emerging harms. This study aimed to identify characteristics and advice provided in cardiac...
Sparad:
Huvudskapare: | , , , , , , |
---|---|
Materialtyp: | Bok |
Publicerad: |
Wiley,
2020-12-01T00:00:00Z.
|
Ämnen: | |
Länkar: | Connect to this object online. |
Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|
Internet
Connect to this object online.3rd Floor Main Library
Signum: |
A1234.567 |
---|---|
Exemplar 1 | Tillgänglig |